L Taylor Davis
Overview
Explore the profile of L Taylor Davis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leguizamon M, Han C, Garza M, Horne M, Richerson W, Davis L, et al.
AJNR Am J Neuroradiol
. 2025 Feb;
PMID: 39993797
Background And Purpose: Anatomical imaging is a hallmark for visualizing chronic and acute infarcts but provides incomplete information on stroke risk. Respiratory hypercapnic gas challenges show promise for non-invasively assessing...
2.
Shiino S, Han C, Garza M, Fusco M, Chitale R, Davis L, et al.
J Neurosurg
. 2025 Feb;
:1-11.
PMID: 39951721
Objective: Both direct and indirect surgical revascularization techniques are commonly applied for the treatment of moyamoya disease and syndrome; however, responses can be heterogeneous and efficacy in the context of...
3.
Han C, Richerson W, Garza M, Rodeghier M, Mishra M, Davis L, et al.
Brain Commun
. 2025 Jan;
7(1):fcae381.
PMID: 39801713
Moyamoya is a non-atherosclerotic intracranial steno-occlusive condition that places patients at high risk for ischaemic stroke. Randomized trials of surgical revascularization demonstrating efficacy in ischaemic moyamoya have not been performed,...
4.
Aumann M, Richerson W, Song A, Martin D, Davis L, Davis S, et al.
Neurology
. 2024 Dec;
104(1):e210191.
PMID: 39705613
Background And Objectives: Sickle cell disease (SCD) is a hemoglobinopathy resulting in hemoglobin-S production, hemolytic anemia, and elevated stroke risk. Treatments include oral hydroxyurea, blood transfusions, and hematopoietic stem cell...
5.
Song A, Richerson W, Richerson W, Aumann M, Aumann M, Waddle S, et al.
Blood Adv
. 2024 Nov;
9(2):386-397.
PMID: 39546745
Patients with sickle cell disease (SCD) are at elevated risk of silent cerebral infarcts and strokes; however, they frequently lack established stroke risk factors (eg, macrovascular arterial steno-occlusion) and the...
6.
Richerson W, Aumann M, Song A, Eisma J, Davis S, Milner L, et al.
J Cereb Blood Flow Metab
. 2024 Sep;
45(3):486-497.
PMID: 39253827
Sickle cell disease (SCD) is the most common genetic blood disorder, characterized by red cell hemolysis, anemia, and corresponding increased compensatory cerebral blood flow (CBF). SCD patients are at high...
7.
Jones R, Ford A, Donahue M, Fellah S, Davis L, Pruthi S, et al.
Neurology
. 2024 Apr;
102(10):e209247.
PMID: 38684044
Background And Objectives: Previously we demonstrated that 90% of infarcts in children with sickle cell anemia occur in the border zone regions of cerebral blood flow (CBF). We tested the...
8.
Cerebrovascular reactivity dispersion as a new biomarker of recent stroke symptomatology in moyamoya
Han C, Richerson W, Garza M, Rodeghier M, Mishra M, Davis L, et al.
medRxiv
. 2024 Mar;
PMID: 38463978
Background: Moyamoya disease (MMD) is a non-atherosclerotic intracranial steno-occlusive condition placing patients at high risk for ischemic stroke. Direct and indirect surgical revascularization can improve blood flow in MMD; however,...
9.
Levy D, Entrup J, Schneck S, Onuscheck C, Rahman M, Kasdan A, et al.
Brain Commun
. 2024 Feb;
6(1):fcae024.
PMID: 38370445
Individuals with post-stroke aphasia tend to recover their language to some extent; however, it remains challenging to reliably predict the nature and extent of recovery that will occur in the...
10.
Gogniat M, Khan O, Bown C, Liu D, Pechman K, Davis L, et al.
Neurobiol Aging
. 2024 Jan;
136:1-8.
PMID: 38280312
Enlarged perivascular spaces (ePVS) may adversely affect cognition. Little is known about how basal ganglia ePVS interact with apolipoprotein (APOE)-ε4 status. Vanderbilt Memory and Aging Project participants (n = 326,...